Drug recall
Erythromycin Topical Gel USP, 2%, Net Wt 30 g tube, Rx only, Manufactured by: Teligent Pharma, Inc., Buena, NJ…
FDA recall event 89560 · Class II · Teligent Pharma, Inc.
Key facts
| Event ID | 89560 |
|---|---|
| Recall numbers | D-0716-2022 |
| Recalling firm | Teligent Pharma, Inc. |
| Product type | Drugs |
| Products | Erythromycin Topical Gel USP, 2%, Net Wt 30 g tube, Rx only, Manufactured by: Teligent Pharma, Inc., Buena, NJ 08310, Distributed by: McKesson Corporation, dba Sky Packaging, 4971 Southridge Blvd… |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary: Firm Initiated |
| Reason for recall | Failed Impurities/Degradation Specifications: Lot not meeting specification for Unknown Max Related Compounds. |
| Initiation date | Feb 7, 2022 |
| Report date | Feb 23, 2022 |
| Termination date | May 9, 2024 |
| City | Buena |
| State | NJ |
| Country | United States |
| FEI number | 1000526875 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: